Dr John R Tesman, MD in Ventura, CA - Emergency Medicine

Dr John R Tesman, MD is a Emergency Medicine physician based in Ventura, California. Dr John R Tesman is licensed to practice in California (license number G68726) and his current practice location is 2705 Loma Vista Rd, Suite 205, Ventura, California. He can be reached at his office (for appointments etc.) via phone at (805) 585-3086.

NPI number for Dr John R Tesman is 1356407340 and his current mailing address is Po Box 1206, Goleta, California. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1356407340.

Contact Information

	Dr John R Tesman, MD
	2705 Loma Vista Rd, Suite 205, Ventura, CA 93003-1581
	(805) 585-3086
	(805) 652-5474

Physician's Profile

Full Name	Dr John R Tesman
Gender	Male
Speciality	Emergency Medicine
Location	2705 Loma Vista Rd, Ventura, California
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1356407340
Provider Enumeration Date: 12/28/2006
Last Update Date: 07/07/2014

Medical Identifiers

Medical identifiers for Dr John R Tesman such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1356407340	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207P00000X	Emergency Medicine	G68726 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr John R Tesman is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr John R Tesman, MD Po Box 1206, Goleta, CA 93116-1206 Ph: (805) 964-3838	Dr John R Tesman, MD 2705 Loma Vista Rd, Suite 205, Ventura, CA 93003-1581 Ph: (805) 585-3086

News Archive

GlaxoSmithKline's CERVARIX recommended by CDC for protection against cervical cancer

GlaxoSmithKline announced today that the U.S. Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP) recommended that CERVARIX® [Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant] be given to girls and young women to protect against cervical pre-cancers and cervical cancer caused by oncogenic HPV 16 and 18.

Antibody-guided drug shows promising activity in ovarian cancer patients with platinum drug-resistant disease

A new antibody-guided drug has shown promising activity in a phase I trial involving ovarian cancer patients with platinum drug-resistant disease, researchers from Dana-Farber Cancer Institute will report today at the annual meeting of the American Association for Cancer Research.

Comparing genomes to understand how mutations affect the COVID-19 pandemic

Now, a new study by researchers at the Massachusetts Institute of Technology and the Center for Computational Biology, Flatiron Institute and published online on the bioRxiv preprint server describes how the use of comparative genomics helps to identify protein-coding and non-coding functional genes.

Reinnervate, Oncotest and SBH partner to offer 3D tumour cell screening services

3D cell culture company Reinnervate Ltd today announced partnerships with two oncology-focussed CRO's to offer 3D tumour cell screening services. The CROs, Oncotest GmbH (Freiburg, Germany) and SBH Sciences (Natick, MA, USA) will both offer a new service for clients wishing to try out cancer 3D cell culture screening for the first time or who wish to evaluate new tumour types in their models.

Oncolytics Biotech issued patent that covers methods for treating cell proliferative disorders

Oncolytics Biotech Inc. today announced that it has been granted its 35th U.S. Patent, # 7,731,951 entitled "Viruses for the Treatment of Cellular Proliferative Disorders." The patent claims cover methods for treating cell proliferative disorders by administering modified vaccinia virus to proliferating cells having an activated Ras-pathway.

Emergency Medicine Doctors in Ventura, CA

Christina L. Matts, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 147 N Brent St, Ventura, CA 93003 Phone: 805-652-5011
Tatevik Simavorian, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 147 N Brent St, Ventura, CA 93003 Phone: 805-948-5672
Dr. David Araujo, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3291 Loma Vista Rd, Ventura, CA 93003 Phone: 805-652-6100 Fax: 805-652-3252
Dr. Ted M Mandryk, MEDICAL DOCTOR Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3291 Loma Vista Rd, Ventura, CA 93003 Phone: 805-652-6165
Richard Cegelski, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Hillmont Ave, Ventura, CA 93003 Phone: 805-652-6165
Dr. Martin L Ehrlich, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3291 Loma Vista Rd, Ventura, CA 93003 Phone: 805-652-6556 Fax: 805-652-6286

Dr John R Tesman, MD - Emergency Medicine in Ventura, CA